Silver Book Fact

For beneficiaries with wet age-related macular degeneration (AMD), annual Medicare part B payments for vision care increased from $1,504 per beneficiary in 1994 to $3,263 in 2006–due in large part to anti-VEGF treatments.

Day, Shelley, Kofi Acquah, Paul P. Lee, Prithvi Mruthyunjaya, and Frank A. Sloan. Medicare Costs for Neovascular Age-Related Macular Degeneration, 1994-2007. Ophthalmol. May 2011; 152(6): 1014-20. http://www.ajo.com/article/S0002-9394%2811%2900410-7/abstract

Reference

Title
Medicare Costs for Neovascular Age-Related Macular Degeneration, 1994-2007
Publication
Ophthalmol
Publication Date
May 2011
Authors
Day, Shelley, Kofi Acquah, Paul P. Lee, Prithvi Mruthyunjaya, and Frank A. Sloan
Volume & Issue
Volume 152, Issue 6
Pages
1014-20
URL
Read Full Resource

Categories

  • Cost of Disease
  • Economic Burden

Related Facts

  • Cataracts removal over age 85
    One in 2 Americans aged 85 years or older stated that their cataracts have been removed.  
  • An estimated 4.1 million Americans age 40 and older have diabetic retinopathy.  
  • A study of Medicare beneficiaries with glaucoma showed that health care costs increased with degree of vision loss–ranging from $8,157 per year for no vision loss to $18,670 for blindness.  
  • Glaucoma is one of the leading causes of blindness among age-related eye diseases in Hispanic persons– accounting for 28.6% of cases of blindness.  
  • Global DR Prevalence
    The overall prevalence of global DR is 34.6%—6.96% for PDR, 6.81% for DME, and 10.2% for vision-threatening DR.